PCN20 REAL LIFE TREATMENT DURATION OF SORAFENIB OR SUNITINIB IN FIRST LINE METASTATIC RENAL CELL CARCINOMA PATIENTS- A COMPARATIVE ANALYSIS
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74272-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)74272-8/fulltext
Title :
PCN20 REAL LIFE TREATMENT DURATION OF SORAFENIB OR SUNITINIB IN FIRST LINE METASTATIC RENAL CELL CARCINOMA PATIENTS- A COMPARATIVE ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74272-8&doi=10.1016/S1098-3015(10)74272-8
First page :
Section Title :
Open access? :
No
Section Order :
200